Table 3. Genotype and allelic frequencies of two polymorphisms assessed in 25 breast cancer patients treated with radiotherapy, 11 normal reactors (NR) and 14 severe reactors (SR).
|
Radiosensitivity groups n (%)
|
Odd ratio | |||
|---|---|---|---|---|
| Genotype and allele | Severe reactors n=14 | Normal reactors n=11 | (95% conf. interval) | Significance level P |
| CDKN1A (codon 31 C>A Ser/Arg) | ||||
| Genotypes | ||||
| C/C | 10 (71) | 8 (73) | ||
| C/A | 4 (29) | 2 (18) | N/A | 1.00* |
| A/A | 0 (0) | 1 (9) | N/A | 0.47* |
| Allelic frequencies | ||||
| C | 24 (86) | 18 (82) | ||
| A | 4 (14) | 4 (18) | N/A | 0.72* |
| TP53 (codon 72 G>C Arg/Pro) | ||||
| Genotypes | ||||
| G/G | 9 (64) | 6 (55) | ||
| G/C | 3 (21) | 3 (27) | N/A | 1.00* |
| C/C | 2 (14) | 2 (18) | N/A | 1.00* |
| Allelic frequencies | ||||
| G | 21 (75) | 15 (68) | ||
| C | 7 (25) | 7 (32) | 0.71 (0.17–2.92) | 0.59 |
N/A=not applicable. *Two-tailed Fisher's Exact test.